Clinical Trial Update: A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and antimicrobial efficacy of DBI-002 Probiotic in adults with tinea versicolor has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Versicolor

Drugs mentioned

• DBI-002 Probiotic

Snippet

Sponsor: DermBiont, Inc. | Conditions: Tinea Versicolor | Phase 2 | Status: COMPLETED | Results posted: 2025-07-03